
<table style="text-align:center"><caption><strong>Newey-West Adjusted Linear Models of Orphan Drug Market Authorizations</strong></caption>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="5"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="5" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="5">Annual Number of Market Authorized Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td><td>Model 5</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">US (β<sup>̂</sup><sub>1</sub>)</td><td>32.389<sup>***</sup></td><td>-11.094</td><td>-5.468</td><td>-41.785<sup>***</sup></td><td>-29.426<sup>***</sup></td></tr>
<tr><td style="text-align:left"></td><td>(10.065)</td><td>(8.482)</td><td>(8.098)</td><td>(7.781)</td><td>(6.679)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004 (β<sup>̂</sup><sub>2</sub>)</td><td>2.788<sup>***</sup></td><td>-1.021</td><td>0.605<sup>***</sup></td><td></td><td>0.123</td></tr>
<tr><td style="text-align:left"></td><td>(0.378)</td><td>(0.621)</td><td>(0.178)</td><td></td><td>(0.653)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD) (β<sup>̂</sup><sub>3</sub>)</td><td></td><td>2.042<sup>***</sup></td><td></td><td>0.461<sup>***</sup></td><td>0.379</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.330)</td><td></td><td>(0.143)</td><td>(0.495)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate Per Capita (β<sup>̂</sup><sub>4</sub>)</td><td></td><td>0.194</td><td>0.245</td><td>0.096</td><td>0.147</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.251)</td><td>(0.150)</td><td>(0.159)</td><td>(0.157)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US (β<sup>̂</sup><sub>5</sub>)</td><td></td><td></td><td>4.451<sup>***</sup></td><td></td><td>1.816</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.772)</td><td></td><td>(1.122)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US (β<sub>6</sub>)</td><td></td><td></td><td></td><td>1.391<sup>***</sup></td><td>0.828</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.173)</td><td>(0.495)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept (β<sup>̂</sup><sub>0</sub>)</td><td>-12.308</td><td>-31.548<sup>***</sup></td><td>5.465<sup>***</sup></td><td>-0.425</td><td>0.413</td></tr>
<tr><td style="text-align:left"></td><td>(7.511)</td><td>(5.181)</td><td>(1.823)</td><td>(3.865)</td><td>(7.268)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">AIC</td><td>305</td><td>278</td><td>273</td><td>266</td><td>266</td></tr>
<tr><td style="text-align:left">RMSE</td><td>14.96</td><td>9.68</td><td>9.11</td><td>8.28</td><td>7.84</td></tr>
<tr><td style="text-align:left">Adj R<sup>2</sup></td><td>0.66</td><td>0.85</td><td>0.87</td><td>0.89</td><td>0.89</td></tr>
<tr><td style="text-align:left">F Statistic</td><td>34.76</td><td>49.77</td><td>57.15</td><td>70.86</td><td>49.88</td></tr>
<tr><td style="text-align:left">p-value</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="5" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
